Noveome Biotherapeutics initiates trial evaluating intranasal delivery of ST266 targeting optic nerve and brain

This article was originally published here

ST266 is a novel “secretome,” cell-free platform biologic, containing hundreds of proteins and other biological factors involved in cellular healing. For delivery to the optic nerve and brain,

The post Noveome Biotherapeutics initiates trial evaluating intranasal delivery of ST266 targeting optic nerve and brain appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply